Research.Patient.info
Prophylaxis of primary liver research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II, Open-Label, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted from a Prograf® Based Immunosuppressive Regimen to a Tacrolimus Prolonged Release, Advagraf® Based Immunosuppressive Regimen, Including a Long-Term Follow Up
This study looks at how a medicine called tacrolimus works in children who have had an organ transplant. Researchers want to compare two versions, Prograf and Advagraf, to see how well they prevent the body from rejecting the new organ, and if Advagraf is a good long-term option.
Czechia - ongoing, recruitingPhase I and Phase II (Integrated)- Other
ABIMMUNE: A Phase I/II study evaluating the safety and clinical activity of anti-PDL1 (Durvalumab [MEDI4736]) + Anti CTLA-4 (Tremelimumab) antibodies administrated in combination with stereotactic body radiotherapy (SBRT) in patients with metastatic squamous cell carcinoma of head and neck, lung, oesophageus, cervix, vagina, vulva or anus.
This study looks at combining new cancer drugs with a special type of radiation for specific cancers that have spread. We want to see if this treatment is safe and if it helps shrink tumours. It's for certain cancers in the head, neck, lung, food pipe, and female private parts.
France